拉伸治療產品市場－全球產業規模、佔有率、趨勢、機會及預測（依產品類型、價格類別、通路、地區及競爭格局分類，2021-2031年）

全球拉伸治療市場預計將從 2025 年的 15.8 億美元成長到 2031 年的 21.7 億美元，複合年成長率為 5.43%。

市場涵蓋乳液、精油和乳霜等外用產品，旨在改善皮膚彈性，減少因懷孕或體重快速變化引起的妊娠紋。推動這一市場成長的主要因素是全球體重管理挑戰日益嚴峻，以及消費者對產後美容護理的日益關注。龐大的消費族群對維持皮膚彈性的預防性產品有著穩定的需求。例如，根據世界肥胖聯盟（WOF）發布的《2024年報告》，全球有超過10億人肥胖，凸顯了龐大的人口群體面臨著皮膚彈性問題以及相應的補救措施需求。

儘管美容產業擁有巨大的成長潛力，但仍面臨著許多障礙，其中之一是許多美容療法缺乏經臨床驗證的療效，導致消費者持懷疑態度。製造商往往難以提供與藥品標準相媲美的嚴格醫學證據來證實其宣傳，這使得潛在買家猶豫不決。這種對療效標準的信任缺失持續限制美容療法的市場普及，並增加了尋求可靠療效的終端使用者在決策流程中的複雜性。

市場促進因素

體重快速波動是拉伸治療市場的主要促進因素，這主要歸因於藥物減重療法的廣泛應用。在短時間內體重顯著下降的人，尤其是使用GLP-1受體促效劑的人，往往會出現皮膚彈性下降，從而導致拉伸的出現。這一趨勢催生了一個特定的消費群體，他們需要能夠恢復藥物減肥後皮膚結構完整性的高效治療方法。根據2024年5月凱撒家庭基金會（KFF）發布的健康追蹤調查，約12%的成年人報告使用過GLP-1促效劑，而體重管理習慣的顯著改變正在推動對皮膚彈性解決方案的需求成長。為此，各大公司正積極推廣專為經歷這些快速身體變化的人群設計的修復霜和精油。

同時，懷孕和產後護膚產品的需求日益成長，而臨床療效和安全性至關重要，這有力地支撐了市場。孕婦從懷孕初期就開始積極進行預防性皮膚護理，以盡量減少皮膚拉伸，並且更傾向於選擇有醫學驗證的品牌而非普通化妝品。這種轉變也體現在專注於治療性護膚的公司的財務表現中。拜爾斯道夫於2024年2月發布的2023年度報告指出，其皮膚科部門（包括Aquaphor和Eucerin等品牌）的有機銷售額成長了24%。同樣，歐萊雅於2024年2月發布的2023年度報告顯示，其皮膚科化妝品部門的銷售額達到64億歐元，凸顯了消費者在這個人生關鍵階段願意投資於經科學驗證的配方產品。

市場挑戰

消費者普遍對局部用藥的臨床療效持懷疑態度，嚴重阻礙了全球拉伸產品市場的成長。許多消費者認為，製造商的宣傳與實際效果之間存在顯著差距，尤其是在許多化妝品級產品缺乏嚴格的醫學證據的情況下。這種不確定性使購買過程更加複雜，因為消費者不願意購買那些無法保證達到與藥物治療同等皮膚科療效的昂貴乳液、精油和乳霜。因此，這種信任缺失導致客戶流失率上升，並在競爭激烈的市場環境中降低了品牌忠誠度。

這種持續的懷疑態度直接縮小了市場規模，因為人們越來越依賴醫療指導，而醫療指導對非處方預防措施的價值提出了質疑。對臨床療效數據的依賴往往對化妝品產業不利。例如，2024年，美國皮膚病學會發布了一項臨床指南，指出使用橄欖油和可可脂等成分的常見家庭療法在預防妊娠紋方面沒有任何效果。這類數據加劇了消費者的猶豫，限制了外用產品的潛在市場，因為使用者可能會因為對療效的懷疑而完全放棄治療。

市場趨勢

隨著消費者，尤其是孕婦，越來越傾向於選擇可追溯的植物來源替代品，潔淨標示和有機配方的興起正在從根本上改變產品開發。這種轉變源於人們對減重計畫和懷孕期間經皮吸收的潛在毒素日益關注，迫使製造商尋求第三方認證以支持其安全保證。統計數據也印證了這種對天然成分的需求。根據美國國家護膚基金會 (NSF) 2025 年 3 月發布的《個人護理產品購買習慣最新消費者資料》，74% 的消費者在選擇個人保健產品時優先考慮有機成分。因此，各大品牌正在重新思考傳統的拉伸霜配方，並去除鄰苯二甲酸酯和對羥基苯甲酸酯。他們將植物來源成分的真實性確立為相對於傳統藥物基產品的關鍵競爭優勢。

同時，經皮和奈米技術遞送系統的創新正在解決產業長期以來面臨的功效難題，提高活性成分向真皮層的滲透性。製造商不再局限於簡單的保濕，而是利用封裝技術將膠原蛋白生成胜肽和類視色素A直接輸送到妊娠紋產生的受損皮膚層。這種向高效、經科學驗證的護膚的轉變，得益於業界對技術進步的大量投資。歐萊雅於2025年2月發布的2024年報告顯示，該公司將在研發和創新方面投資超過13億歐元。這項巨額資源投入標誌著產業策略從遮瑕轉向治療級修復，旨在縮小外用產品與侵入性臨床手術之間的效果差距。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球拉伸治療產品市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 依產品類型（乳霜、身體乳、潤膚露、精華液、按摩油）
  • 依價格類別（大眾市場、高階市場）
  • 按分銷管道（超級市場/超級市場、藥局/藥局、專賣店、線上、其他）
  • 按地區
  • 按公司（2025 年）
• 市場地圖

6. 北美拉伸產品市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國家分析
  • 美國
  • 加拿大
  • 墨西哥

7. 歐洲拉伸產品市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國家分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

8. 亞太地區拉伸治療產品市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國家分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

9. 中東和非洲拉伸治療產品市場展望

• 市場規模及預測
• 市佔率及預測
• 中東和非洲：國家分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美洲拉伸產品市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國家分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進要素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 最新進展

第13章 全球拉伸治療產品市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的可能性
• 供應商電力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• Clarins Group
• ET Browne Drug Co., Inc.
• Basq Skin Care, Inc.
• Weleda, Inc.
• Dermaclara, LLC
• Mama Mio Ltd
• L'Oreal SA
• Luxor Investments LLC
• Honasa Consumer Ltd.
• Himalaya Global Holdings Ltd.

第16章 策略建議

第17章：關於研究公司及免責聲明

The Global Anti-Stretch Mark Products Market is projected to expand from USD 1.58 Billion in 2025 to USD 2.17 Billion by 2031, reflecting a compound annual growth rate of 5.43%. This market encompasses topical solutions like lotions, oils, and creams specifically developed to enhance skin elasticity and reduce the visibility of striae resulting from pregnancy or rapid weight changes. A primary factor fueling this growth is the increasing global prevalence of weight management challenges combined with a heightened consumer focus on postpartum aesthetic care. This broad demographic creates consistent demand for preventive skin resilience products. For instance, the World Obesity Federation reported in 2024 that over one billion individuals globally were living with obesity, underscoring the vast population vulnerable to skin stretching issues and the subsequent need for corrective measures.

Despite this growth potential, the industry faces a substantial hurdle related to the perceived absence of clinical efficacy in many cosmetic treatments, which breeds consumer skepticism. Manufacturers frequently encounter difficulties in validating their claims with rigorous medical evidence that matches pharmaceutical standards, causing hesitation among prospective buyers. This gap in trust concerning performance standards continues to limit wider market adoption and adds complexity to the decision-making process for end users who are looking for assured results.

Market Driver

The increasing incidence of rapid weight fluctuations acts as a pivotal driver for the anti-stretch mark products sector, largely driven by the widespread use of pharmaceutical weight-loss treatments. As individuals undergo significant body mass reduction over short periods, especially through the usage of GLP-1 receptor agonists, their skin often fails to maintain elasticity, resulting in striae formation. This trend has created a specific consumer group demanding high-performance topical remedies to restore skin structural integrity after medical weight management. According to the 'KFF Health Tracking Poll' from May 2024, roughly 12% of adults reported utilizing a GLP-1 agonist, indicating a major shift in weight control habits that stimulates downstream demand for skin resilience solutions. Consequently, companies are actively promoting corrective creams and oils specifically designed for those experiencing these intensive physical changes.

Concurrently, the market is strongly supported by the growing need for maternity and post-pregnancy skincare options where clinical efficacy and safety are essential. Expectant mothers are increasingly adopting preventive dermatological routines early in pregnancy to minimize skin stretching, favoring brands with robust medical credentials over standard cosmetic options. This shift is highlighted by the financial results of firms focused on therapeutic skincare; Beiersdorf's 'Annual Report 2023', released in February 2024, noted that their Derma business unit, featuring brands like Aquaphor and Eucerin, saw organic sales rise by 24%. Similarly, L'Oreal's '2023 Annual Report' from February 2024 showed their Dermatological Beauty Division achieved sales of 6.4 billion euros, demonstrating that consumers are willing to invest in scientifically backed formulations during pivotal life moments.

Market Challenge

Widespread consumer skepticism concerning the clinical effectiveness of topical formulations represents a major obstacle to the growth of the Global Anti-Stretch Mark Products Market. Many buyers feel there is a significant discrepancy between manufacturer marketing claims and visible outcomes, especially given the scarcity of rigorous medical proof for numerous cosmetic-grade products. This uncertainty makes the purchasing journey difficult, as consumers are hesitant to spend on expensive lotions, oils, or creams that cannot promise dermatological benefits similar to pharmaceutical treatments. As a result, this lack of trust elevates customer turnover and diminishes brand loyalty within a highly competitive market environment.

This lingering skepticism directly reduces market volume as individuals increasingly defer to medical guidance that questions the value of over-the-counter preventive measures. The reliance on clinical efficacy data often disadvantages the cosmetic industry. For example, in 2024, the American Academy of Dermatology Association released clinical guidelines stating that popular home remedies utilizing ingredients like olive oil or cocoa butter showed a 0 percent efficacy rate in preventing striae during pregnancy. Such data reinforces consumer hesitation, thereby restricting the potential market for topical solutions as users may choose to forego treatment altogether due to doubts regarding performance.

Market Trends

The rise of Clean Label and Organic Formulations is fundamentally reshaping product development as consumers, especially expectant mothers, increasingly avoid synthetic additives in favor of traceable, plant-based alternatives. This transition is fueled by intensified scrutiny regarding the transdermal absorption of potential toxins during weight loss regimens and pregnancy, forcing manufacturers to obtain third-party certifications to substantiate safety assurances. This demand for natural purity is backed by statistics; according to NSF's 'New Consumer Data on Personal Care Purchasing Habits' from March 2025, 74% of consumers prioritize organic ingredients in personal care items. Consequently, brands are reworking legacy stretch mark creams to eliminate phthalates and parabens, establishing botanical integrity as a key competitive advantage against traditional pharmaceutical options.

Simultaneously, innovation in Transdermal and Nanotech Delivery Systems is tackling the industry's historic efficacy challenges by improving the absorption of active compounds into the dermis. Manufacturers are advancing beyond simple hydration by employing encapsulation technologies to deliver collagen-stimulating peptides and retinoids directly to the damaged skin layers where striae form. This shift toward high-performance, scientifically validated skincare is demonstrated by significant industry spending on technical progress; L'Oreal's '2024 Annual Report', published in February 2025, reveals an investment of over 1.3 billion euros in Research & Innovation. Such considerable resource allocation highlights a strategic move from cosmetic concealers to therapeutic-grade reparative treatments, aimed at narrowing the performance disparity between topical applications and invasive clinical procedures.

Key Market Players

• Clarins Group
• E.T. Browne Drug Co., Inc.
• Basq Skin Care, Inc.
• Weleda, Inc.
• Dermaclara, LLC
• Mama Mio Ltd
• L'Oreal S.A.
• Luxor Investments LLC
• Honasa Consumer Ltd.
• Himalaya Global Holdings Ltd.

Report Scope

In this report, the Global Anti-Stretch Mark Products Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Anti-Stretch Mark Products Market, By Product Type

• Creams
• Body Butter
• Lotions
• Serum
• Massage Oil

Anti-Stretch Mark Products Market, By Price Category

• Mass
• Premium

Anti-Stretch Mark Products Market, By Distribution Channel

• Hypermarkets/Supermarkets
• Pharmacy/Drug Stores
• Specialty Stores
• Online
• Others

Anti-Stretch Mark Products Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Anti-Stretch Mark Products Market.

Available Customizations:

Global Anti-Stretch Mark Products Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Anti-Stretch Mark Products Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product Type (Creams, Body Butter, Lotions, Serum, Massage Oil)
  • 5.2.2. By Price Category (Mass, Premium)
  • 5.2.3. By Distribution Channel (Hypermarkets/Supermarkets, Pharmacy/Drug Stores, Specialty Stores, Online, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Anti-Stretch Mark Products Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product Type
  • 6.2.2. By Price Category
  • 6.2.3. By Distribution Channel
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Anti-Stretch Mark Products Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product Type
      • 6.3.1.2.2. By Price Category
      • 6.3.1.2.3. By Distribution Channel
  • 6.3.2. Canada Anti-Stretch Mark Products Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product Type
      • 6.3.2.2.2. By Price Category
      • 6.3.2.2.3. By Distribution Channel
  • 6.3.3. Mexico Anti-Stretch Mark Products Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product Type
      • 6.3.3.2.2. By Price Category
      • 6.3.3.2.3. By Distribution Channel

7. Europe Anti-Stretch Mark Products Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product Type
  • 7.2.2. By Price Category
  • 7.2.3. By Distribution Channel
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Anti-Stretch Mark Products Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product Type
      • 7.3.1.2.2. By Price Category
      • 7.3.1.2.3. By Distribution Channel
  • 7.3.2. France Anti-Stretch Mark Products Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product Type
      • 7.3.2.2.2. By Price Category
      • 7.3.2.2.3. By Distribution Channel
  • 7.3.3. United Kingdom Anti-Stretch Mark Products Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product Type
      • 7.3.3.2.2. By Price Category
      • 7.3.3.2.3. By Distribution Channel
  • 7.3.4. Italy Anti-Stretch Mark Products Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product Type
      • 7.3.4.2.2. By Price Category
      • 7.3.4.2.3. By Distribution Channel
  • 7.3.5. Spain Anti-Stretch Mark Products Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product Type
      • 7.3.5.2.2. By Price Category
      • 7.3.5.2.3. By Distribution Channel

8. Asia Pacific Anti-Stretch Mark Products Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product Type
  • 8.2.2. By Price Category
  • 8.2.3. By Distribution Channel
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Anti-Stretch Mark Products Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product Type
      • 8.3.1.2.2. By Price Category
      • 8.3.1.2.3. By Distribution Channel
  • 8.3.2. India Anti-Stretch Mark Products Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product Type
      • 8.3.2.2.2. By Price Category
      • 8.3.2.2.3. By Distribution Channel
  • 8.3.3. Japan Anti-Stretch Mark Products Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product Type
      • 8.3.3.2.2. By Price Category
      • 8.3.3.2.3. By Distribution Channel
  • 8.3.4. South Korea Anti-Stretch Mark Products Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product Type
      • 8.3.4.2.2. By Price Category
      • 8.3.4.2.3. By Distribution Channel
  • 8.3.5. Australia Anti-Stretch Mark Products Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product Type
      • 8.3.5.2.2. By Price Category
      • 8.3.5.2.3. By Distribution Channel

9. Middle East & Africa Anti-Stretch Mark Products Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product Type
  • 9.2.2. By Price Category
  • 9.2.3. By Distribution Channel
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Anti-Stretch Mark Products Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product Type
      • 9.3.1.2.2. By Price Category
      • 9.3.1.2.3. By Distribution Channel
  • 9.3.2. UAE Anti-Stretch Mark Products Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product Type
      • 9.3.2.2.2. By Price Category
      • 9.3.2.2.3. By Distribution Channel
  • 9.3.3. South Africa Anti-Stretch Mark Products Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product Type
      • 9.3.3.2.2. By Price Category
      • 9.3.3.2.3. By Distribution Channel

10. South America Anti-Stretch Mark Products Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product Type
  • 10.2.2. By Price Category
  • 10.2.3. By Distribution Channel
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Anti-Stretch Mark Products Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product Type
      • 10.3.1.2.2. By Price Category
      • 10.3.1.2.3. By Distribution Channel
  • 10.3.2. Colombia Anti-Stretch Mark Products Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product Type
      • 10.3.2.2.2. By Price Category
      • 10.3.2.2.3. By Distribution Channel
  • 10.3.3. Argentina Anti-Stretch Mark Products Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product Type
      • 10.3.3.2.2. By Price Category
      • 10.3.3.2.3. By Distribution Channel

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Anti-Stretch Mark Products Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Clarins Group
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. E.T. Browne Drug Co., Inc.
• 15.3. Basq Skin Care, Inc.
• 15.4. Weleda, Inc.
• 15.5. Dermaclara, LLC
• 15.6. Mama Mio Ltd
• 15.7. L'Oreal S.A.
• 15.8. Luxor Investments LLC
• 15.9. Honasa Consumer Ltd.
• 15.10. Himalaya Global Holdings Ltd.

16. Strategic Recommendations

17. About Us & Disclaimer